Pulse Biosciences, Inc.PLSENASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P36
Within normal range
vs 3Y Ago
-3.7x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-48.92%
2024-9.99%
202329.72%
202213.09%
2021-52.97%
2020-3.45%
2019-43.06%
2018-115.53%
2017-37.71%
2016-142.74%